tosufloxacin has been researched along with Acute Disease in 4 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effectiveness of a single 300-mg dose of tosufloxacin and of 3-day treatment with tosufloxacin (300 mg daily) were compared in a prospective trial in order to clarify the cost-effectiveness of tosufloxacin for acute uncomplicated cystitis." | 7.68 | [Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis]. ( Endou, K; Goto, H; Igarashi, H; Kawahara, M; Kiyota, H; Machida, T; Masuda, F; Ohishi, Y; Onodera, S; Suzuki, H, 1992) |
| "The effectiveness of a single 300-mg dose of tosufloxacin and of 3-day treatment with tosufloxacin (300 mg daily) were compared in a prospective trial in order to clarify the cost-effectiveness of tosufloxacin for acute uncomplicated cystitis." | 3.68 | [Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis]. ( Endou, K; Goto, H; Igarashi, H; Kawahara, M; Kiyota, H; Machida, T; Masuda, F; Ohishi, Y; Onodera, S; Suzuki, H, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ubukata, K | 1 |
| Morozumi, M | 1 |
| Sakuma, M | 1 |
| Adachi, Y | 1 |
| Mokuno, E | 1 |
| Tajima, T | 1 |
| Iwata, S | 1 |
| Koga, H | 1 |
| Aoyagi, K | 1 |
| Yoshimura, R | 1 |
| Kimura, Y | 1 |
| Iida, M | 1 |
| Fujishima, M | 1 |
| Kiyota, H | 1 |
| Machida, T | 1 |
| Masuda, F | 1 |
| Ohishi, Y | 1 |
| Onodera, S | 1 |
| Suzuki, H | 1 |
| Goto, H | 1 |
| Kawahara, M | 1 |
| Igarashi, H | 1 |
| Endou, K | 1 |
| Aoki, T | 1 |
| Matsubara, Y | 1 |
| Sagara, H | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Nitta, Y | 1 |
| Seo, T | 1 |
| Kamimura, M | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
1 trial available for tosufloxacin and Acute Disease
| Article | Year |
|---|---|
[Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
Topics: 4-Quinolones; Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Bacterial Inf | 1989 |
3 other studies available for tosufloxacin and Acute Disease
| Article | Year |
|---|---|
Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporin | 2019 |
Can quinolones cause hemorrhagic colitis of late onset? Report of three cases.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Colitis; Colonoscopy; Enoxacin; F | 1999 |
[Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis].
Topics: 4-Quinolones; Acute Disease; Adult; Aged; Anti-Infective Agents; Bacteria; Cystitis; Female; Fluoroq | 1992 |